Opioid Distributor, 2 Execs Are Charged, Plead Or Settle Conspiracy, Fraud Claims
NEW YORK — In what a U.S. attorney described as a first-of-its-kind action, the United States on April 23 secured a consent decree and a $20 million penalty from a pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article